格隆汇1月7日丨完美医疗(01830.HK)宣布，于2026年1月7日，公司根据其于2021年8月13日采纳的购股 权计划已向公司合资格雇员(「承授人」)授出376.8万份购股权，惟须待承授人接纳后方告作实。 ...

完美医疗(01830)发布公告，于2026年1月7日，公司根据其于2021年8月13日采纳的购股权计划已向公司 合资格雇员授出376.8万份购股权，惟须待承授人接纳后方告作实。该等购股权赋予承授人权利认购公 司股本中合共376.8万股每股面值0.1港元的新普通股，占本公布日期所有已发行股份约0.30%。 ...

智通财经APP讯，完美医疗(01830)发布公告，于2026年1月7日，公司根据其于2021年8月13日采纳的购 股权计划已向公司合资格雇员授出376.8万份购股权，惟须待承授人接纳后方告作实。该等购股权赋予 承授人权利认购公司股本中合共376.8万股每股面值0.1港元的新普通股，占本公布日期所有已发行股份 约0.30%。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司（「聯交所」）對本公佈的內容概不負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部 份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 PERFECT MEDICAL HEALTH MANAGEMENT LIMITED 完美醫療健康管理有限公司 （於開曼群島註冊成立之有限公司） （股份代號：1830） 授出購股權 本公佈乃根據聯交所證券上市規則（「上市規則」）第17.06A條作出。 完美醫療健康管理有限公司（「本公司」）及其附屬公司（統稱「本集團」）董事（「董事」）會（「董 事會」）欣然宣佈，於二零二六年一月七日，本公司根據其於二零二一年八月十三日採納的 購股權計劃（「該計劃」）已向本公司合資格僱員（「承授人」）授出3,768,000份購股權（「該等購 股權」），惟須待承授人接納後方告作實。該等購股權賦予承授人權利認購本公司股本中合 共3,768,000股每股面值0.1港元的新普通股（「股份」），佔本公佈日期所有已發行股份約 0.30%。所授出該等購股權的詳情如下： 授出日期 ： 二零二六年一月七日（「授出日期」） 所授出 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 完美醫療健康管理有限公司 呈交日期: 2026年1月6日 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01830 | 說明 | | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | | 1,256,197,771 | | 0 | | 1,256,197,771 | | 增加 / 減少 (-) | | | | | | | | | | 本月底結存 | | | | 1,256,197,771 | | 0 | | 1,256,197,771 | 第 2 頁 共 10 頁 v 1.1.1 I ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 完美醫療健康管理有限公司 呈交日期: 2026年1月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01830 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | HKD | | 0.1 | HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 10,000,000,000 | HKD | | 0.1 | HKD | | 1,000,000,000 | I ...

PERFECT MEDICAL HEALTH MANAGEMENT LIMITED 完美醫療健康管理有限公司 (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立之有限公司） Perfect Medical Health Management Limited So Hin Lung (Stock Code: 1830) （股份代號：1830） Dear Non-Registered Holder(s)1 , Notification of Publication of Corporate Communication on the Company's Website We hereby notify you that the following corporate communication (the "Current Corporate Communication") of Perfect Medical Health Management Limited (the "Company"), in both English ...

Notification of Publication of Corporate Communication on the Company's Website We hereby notify you that the following corporate communication (the "Current Corporate Communication") of Perfect Medical Health Management Limited (the "Company"), in both English and Chinese versions, are now available on the Company's website at www.perfectmedical.com and the website of Hong Kong Exchanges and Clearing Limited (the "HKEXnews website") at www.hkexnews.hk: • Interim Report 2025/2026 PERFECT MEDICAL HEALTH MANA ...

Core Viewpoint - Perfect Medical (01830.HK) reported a 21.7% decrease in revenue to HKD 486 million for the six months ending September 30, 2025, with a profit attributable to equity holders of HKD 94.8 million, reflecting a 32.7% decline year-on-year, although a 43.4% increase compared to the previous six-month period [1] Financial Performance - Revenue decreased by 21.7% to HKD 486 million [1] - Profit attributable to equity holders was HKD 94.8 million, down 32.7% year-on-year but up 43.4% from the previous six-month period [1] - Basic earnings per share were HKD 0.075 [1] - Proposed interim dividend is HKD 0.076 per share, with a payout ratio of 101.3% [1] - The company has maintained a payout ratio of 100% or above for eleven consecutive years [1] Market Environment - The core Hong Kong market continues to face structural challenges impacting discretionary spending in service categories [1] - Although overall retail sales have shown slight recovery since May 2025 due to inbound tourism, the recovery is primarily in retail goods rather than medical beauty services [1] - The increase in outbound travel and overseas spending by local residents has significantly affected the company's performance by draining discretionary income from the local service market [1] - A cooling labor market and changing consumer habits have led to a more cautious overall consumption sentiment, resulting in a noticeable decline in consumer willingness to spend on medical beauty and beauty services [1] - Multiple factors have temporarily limited revenue growth and significantly impacted the company's mid-term financial performance [1]

Core Viewpoint - Perfect Medical (01830) reported a significant decline in revenue and profit for the six months ending September 30, 2025, indicating potential challenges in its business operations [1] Financial Performance - Revenue decreased by 21.7% year-on-year to HKD 486 million [1] - Profit attributable to equity holders fell by 32.7% to HKD 94.8 million [1] - Basic earnings per share were HKD 0.075 [1] - The company proposed an interim dividend of HKD 0.076 per share [1]